SCHEMBL24816707

SCHEMBL24816707

COCc1cc(Nc2ncc(Cl)c(Nc3ccccc3P(C)(C)=O)n2)c(OC)cc1N1CCC(N2CCNCC2)CC1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALK Q9UM73 13/20 0.70
▸ INSR P06213 10/20 0.70
▸ IGF1R P08069 10/20 0.70
▸ EGFR P00533 7/20 0.66
▸ CHEK1 O14757 1/20 0.65
▸ AURKA O14965 1/20 0.65
▸ NUAK1 O60285 1/20 0.65
▸ JAK2 O60674 1/20 0.65
▸ STK10 O94804 1/20 0.65
▸ PRKD3 O94806 1/20 0.65
▸ SLC34A2 O95436 1/20 0.65
▸ CHEK2 O96017 1/20 0.65
▸ ABL1 P00519 1/20 0.65
▸ CD74 P04233 1/20 0.65
▸ ERBB2 P04626 1/20 0.65
▸ LCK P06239 1/20 0.65
▸ FYN P06241 1/20 0.65
▸ FES P07332 1/20 0.65
▸ CSF1R P07333 1/20 0.65
▸ YES1 P07947 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24816811 0.94 ALK (0.72) ALKINSRIGF1REGFRCHEK1
SCHEMBL24816839 0.93 ALK (0.70) ALKINSRIGF1REGFRCHEK1
SCHEMBL24816908 0.91 ALK (0.68) ALKINSRIGF1REGFRCHEK1
SCHEMBL24590679 0.90 ALK (0.85) ALKINSRIGF1REGFRCHEK1
SCHEMBL24816639 0.89 ALK (0.72) ALKINSRIGF1REGFRCHEK1
SCHEMBL24818186 0.88 EGFR (0.67) ALKINSRIGF1REGFRCHEK1
SCHEMBL24818153 0.88 ALK (0.70) ALKINSRIGF1REGFRCHEK1
SCHEMBL24817991 0.88 ALK (0.76) ALKINSRIGF1REGFRCHEK1
SCHEMBL24817766 0.87 EGFR (0.72) ALKINSRIGF1REGFRCHEK1
SCHEMBL24817939 0.87 ALK (0.84) ALKINSRIGF1REGFRCHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022268229-A1 PROTEIN INHIBITOR OR DEGRADING AGENT, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND PHARMACEUTICAL USE 和径医药科技(上海)有限公司 2022-12-29 — — WO disclosed
Send feedback